The study has shown a substantial improvement in biological naïve patients with active disease, in particular in decreasing IL-17A, IL-17F, and CRP serum levels by week 16 achieving Psoriasis Score and Severity Index, PASI75 (99, 100). This evidence concerns the gene IL17F and psoriasis.